30.000
+0,00%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +53.9% | +68.6% | 3 / 3 | +72.0% | -3.02 pp | -0.29 pp | +30.3% | 0.00 | 4.49 | 527 | +72,0% | 13,2 | +53,9% | 4.49 | 8.31 | −46,0% |
| Pts | 8 | 12 | 12 | 12 | 0 | 4 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 30.000 (close price on 2026-10-19)EPS (TTM): 6.688
Financial charts
1.Revenue & growth
VND bn526Q2/26
1.Revenue & growth
VND bn526Q2/26
2.Profit & growth
VND bn13,1Q2/26
3.Profit mix (Penman)
VND bn61,4Q2/26
4.Margins & cost structure
%10.6%Q2/26
5.Returns & cash cycle
% · days44.3%Q2/26
6.Earnings quality & cash
VND bn55,6Q2/26
7.Asset structure
VND bn283Q2/26
8.Funding & debt health
VND bn · times283Q2/26
9.Revenue backlog
VND bn1,84Q2/26
10.Valuation
times · %4,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.788Q2/26
Adjusted EPS growth, latest quarter
52.8%
Average adjusted EPS growth, 3 quarters
68.3%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26